🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether fusion technique of prera...
Status
Completed
Location
Seoul National University Hospital
Start Date
2015-11
Trial ID
NCT02967198
Treatments Being Tested
This phase II MATCH treatment trial tests how well BVD-523FB (ulixertinib) ...
Status
Active Not Recruiting
Location
ECOG-ACRIN Cancer Research Group
Start Date
2019-07-24
Trial ID
NCT06400225
This early phase I trial tests the safety and how well N-803 works in treat...
Status
Recruiting
Location
Northwestern University
Start Date
2026-04-13
Trial ID
NCT07261657
To prospectively evaluate the technical success rate of real-time computed ...
Status
Completed
Location
Multiple Locations
Start Date
2015-08-01
Trial ID
NCT04844112
Treatments Being Tested
This phase II trial compares the effect of GI-102 alone and in combination ...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2026-04-01
Trial ID
NCT07301268
This is a phase 3, open-label, multicenter, randomized controlled phase III...
Status
Completed
Location
Cancer Center, Sun Yat-sen University
Start Date
2018-01-30
Trial ID
NCT03387774
Treatments Being Tested
This phase II MATCH screening and multi-sub-trial studies how well treatmen...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2015-08-17
Trial ID
NCT02465060
Treatments Being Tested
This Phase 3 study will target approximately 100 men over age 18 who have a...
Status
Completed
Location
Decatur Memorial Hospital
Start Date
2014-10
Trial ID
NCT02260817
Treatments Being Tested
Patients with more advanced stages of cervix cancer are treated by radiothe...
Status
Completed
Location
Cross Cancer Institute
Start Date
2004-11
Trial ID
NCT00126841
Treatments Being Tested
This phase II trial studies the side effects and how well blinatumomab and ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2015-06-30
Trial ID
NCT02143414